HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2635-2644

  Ito, Kouichi ^a   Bian, Hong Jin ^a   Molina, Margarita ^a   Han, Jihong ^a   Magram, Jeanne ^a   Saar, Elizabeth ^a   Belunis, Charles ^a   Bolin, David R ^a   Arceo, Reynaldo ^b   Campbell, Robert ^a   Falcioni, Fiorenza ^a   Vidović, Damir ^a   Hammer, Juergen ^c   Nagy, Zoltan A ^a  

^a Dept Inflammation Autoimmune Dis ^*  (United States)

^b Hoffmann La Roche Department of Toxicology and Pathology   (United States)

^c ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN;

ACTIVE IMMUNIZATION; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; COMBINED IMMUNODEFICIENCY; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; HLA TYPING; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; AUTOIMMUNE DISEASES; BASE SEQUENCE; BINDING SITES; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; DNA PRIMERS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENES, MHC CLASS II; HLA-DR ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; INFLAMMATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; MYELIN PROTEINS; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; SPINAL CORD; T-LYMPHOCYTES;

EID: 15844398106     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2635     Document Type: Article

References (33)

1. Woods, A., H.Y. Chen, M.E. Trumbauer, A. Sirotina, R. Cummings, and D.M. Zaller. 1994. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J. Exp. Med. 180:173-181.
2. Fugger, L., S.A. Michie, I. Rulifson, C.B. Lock, and G.S. McDevitt. 1994. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region β-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc. Natl. Acad. Sci. USA. 91:6151-6155.
3. Nabozny, G.H., J.M. Baisch, S. Cheng, D. Cosgrove, M.M. Griffiths, H.S. Luthra, and C.S. David. 1996. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183:27-37.
4. Pettinelli, C.B., R.B. Fritz, H.J. Chou C, and D.E.J. McFarlin. 1982. Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. Immunology. 129:1209-1211.
5. Fritz, R.B., H.J. Chou C, and D.E. McFarlin. 1983. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J. Immunol. 130:1024-1026.
6. Enddoh, M., T. Tabira, T. Kunishita, K. Sakai, T. Yamamura, and T. Taketomi. 1986. DM-20, a proteolipid apoprotein, is an encephalitogen of acute and relapsing autoimmune encephalomyelitis in mice. J. Immunol. 137:3832-3835.
7. Zamvil, S., P. Nelson, J. Trotter, D. Mitchell, R. Knobler, R. Fritz, and L. Steinman. 1985. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature (Lond.). 317:355-358.
8. Ota, K., M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature (Lond.). 346:183-187.
9. Martin, R., D. Jaraquemada, M. Flerlage, J. Richert, J. Whitaker, E.O. Long, D.E. Mcfarlin, and H.F. Mcfarland. 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:540-548.
10. Pette, M., K. Fujita, D. Wilkinson, D.M. Altmann, J. Trowsdale G. Giegerich, A. Hinkkanen, J.T. Epplen, L. Kappos, and H. Wekerle. 1990. Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA. 87: 7968-7972.
11. + cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148:1359-1366.
12. Markovic-Plese, S., H. Fukaura, J. Zhang, A. Al-Sabbagh, S. Southwood, A. Sette, V.K. Kuchroo, and D.A. Hafler. 1995. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155:982-992.
13. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H.L. Weiner, and D.A. Hafler. 1994. Increased frequency of Interleukin 2-responsive T cell specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973-984.
14. Kawai, J., A. Ando, T. Sato, T. Nakatsuji, K. Tsuji, and H. Inoko. 1989. Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells. J. Immunol. 142:312-317.
15. Steinmetz, M., K. Minard, S. Horvath, J. McNicholas, J. Frelinger, C. Wake, E. Longe, B. Mach, and L. Hood. 1982. A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature (Lond.). 300:35-42.
16. Saito, H., R.A. Maki, L.K. Clayton, and S. Tonegawa. 1983. Complete primary structures of the Eβ chain and gene of the mouse major histocompatibility complex. Proc. Natl. Acad. Sci. USA. 80:5520-5524.
17. Barany, G., and R.B. Merrifield. 1980. The Peptides. Academic Press, New York. 2:1-287.
18. Glimcher, L.H., D.J. McKean, E. Choi, and G. Seidman. 1985. Complex regulation of class II gene expression: analysis with class II mutant cell lines. J. Immunol. 135:3542-3550.
19. + T cells in major histocompatibility complex class II-deficient mice. Science (Wash. DC). 253:1417-1420.
20. Lawrance, S.K., L. Karisson, J. Price, V. Quaranta, Y. Ron, J. Sprent, and P.A. Peterson. 1989. Transgenic HLA-DRα faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to Eα in Eα○ mutant mice. Cell. 58: 583-594.
21. Gosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHG class II molecules. Cell. 66:1051-1066.
22. Hammer, J., P. Valsasnini, K. Tolba, D. Bolin, J. Higelin, B. Takacs, and F. Sinigaglia. 1993. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell. 74:197-203.
23. Hammer, J., C. Belunis, D. Bolin, J. Papadopoulos, R. Walsky, J. Higelin, W. Danho, F. Sinigaglia, and Z.A. Nagy. 1994. High affinity binding of short peptides to MHC class II molecules by anchor combination. Proc. Natl. Acad. Sci. USA. 91:4456-4460.
24. Cammarota, G., A. Scheirle, B. Takacs, D.M. Doran, R. Knorr, W. Bannwarth, J. Guardiola, and F. Sinigaglia. 1992. Identification of a CD4 binding domain of HLA-DR molecule. Nature (Lond.). 356:799-801.
25. Vidović, D., F. Falcioni, B. Siklodi, C.J. Belunis, D.R. Bolin, K. Ito, and Z.A. Nagy. 1996. Downregulation of Class II major histocompatibility complex molecules on antigen-presenting cells by antibody fragments. Eur. J. Immunol. 25:3349-3355.
26. Altmann, D.M., D.C. Douek, A.J. Frater, C.M. Hetherington, H. Inoko, and J.I. Elliott. 1995. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J. Exp. Med. 181:867-875.
27. Fleury, S., J. Thibodeau, G. Croteau, N. Labrecque, H.E. Aronson, C. Cantin, E.O. Long, and R.P. Sekaly. 1995. HLA-DR polymorphism affect the interaction with CD4. J. Exp. Med. 182:733-741.
28. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E.O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecule. Nature (Lond.). 375:603-606.
29. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell. 80:707-718.
30. Lee, B.K., and E.M. Eicher. 1995. Segregation patterns of endogenous mouse mammary tumor viruses in five recombinant inbred strain sets. J. Virol. 64:4568-4572.
31. Scherer, M. T., L. Ignatowicz, A. Pullen, J. Kappler, and P. Marrack. 1995. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire. J. Exp. Med. 182:1493-1504.
32. Lai, E., P. Concannon, and L. Hood. 1988. Conserved organization of the human and murine T-cell receptor β-gene families. Nature (Lond.). 331:543-546.
33. Kuchroo, V.K., M. Collins, A. Al-Sabbagh, R.A. Sobel, M.J. Whitters, S.S. Zamvil, M.E. Dorf, D.A. Hafler, J.G. Seidman, H.L. Weiner, and I.J. Rimm. 1994. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR Vβ 8.2 transgenic mice. J. Exp. Med. 179:1659-1664.